切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Syk - Voltage-gated Calcium Channels (CaV) - PP4 - KDM

22件产品中的 11-20

页面
每页
清除全部
  1. Verapamil HCl
    B1867 Verapamil HCl
     1 Citation
    中文名: 盐酸维拉帕米
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: L-型钙通道阻断剂
      ≥14.45 mg/mL
      ≥6.41 mg/mL
  2. Nisoldipine
    B1989 Nisoldipine
    中文名: 尼索地平
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: 钙通道阻断剂
      ≥11.55 mg/mL
      insoluble in H2O
  3. Fostamatinib (R788)
    B2284 Fostamatinib (R788)
    中文名: 福坦替尼
    Target: Syk
    Summary: 脾酪氨酸激酶(Syk)抑制剂
      ≥100.4 mg/mL
      insoluble in H2O
  4. R406
    A8546 R406
     1 Citation
    Target: Syk
    Summary: SYK抑制剂
      ≥31.45 mg/mL
      insoluble in H2O
  5. R788 disodium
    A8332 R788 disodium
    中文名: 福他替尼二钠盐
    Target: Syk
    Summary: Syk的ATP竞争性抑制剂
      ≥62.4 mg/mL
      ≥2.53 mg/mL
  6. Zonisamide
    A5354 Zonisamide
    中文名: 唑尼沙胺
    Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) Channels
    Summary: 抗惊厥和机械效应的抗癫痫药
      ≥8.35 mg/mL
      insoluble in H2O
  7. Fostriecin sodium salt
    A4536 Fostriecin sodium salt
    Target: PP1|PP2A|Topoisomerases|PP4
    Summary: 抗肿瘤抗生素
      Soluble in H2O
  8. PRT062607 Hydrochloride
    A3736 PRT062607 Hydrochloride
     1 Citation
    Target: Syk
    Summary: SYK抑制剂
      ≥21.5 mg/mL
      ≥83.2 mg/mL
  9. NNC 55-0396
    A3662 NNC 55-0396
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: T型钙离子通道阻断剂
      Soluble to 25 mM in sterile water
  10. Mibefradil
    A3604 Mibefradil
    中文名: 米贝拉地尔,米贝地尔,咪拉地尔,咪贝地尔
    Target: Voltage-gated Calcium Channels (CaV)
    Summary: 钙通道阻滞剂
      ≥49.6 mg/mL
      ≥96.8 mg/mL

22件产品中的 11-20

页面
每页